BR112015029468A8 - sistemas de dosagem oralmente administráveis, método para suplementar a nutrição de ferro em um indivíduo humano e métodos para mitigar um ou mais efeitos adversos gastrointestinais de ferro não absorvido - Google Patents
sistemas de dosagem oralmente administráveis, método para suplementar a nutrição de ferro em um indivíduo humano e métodos para mitigar um ou mais efeitos adversos gastrointestinais de ferro não absorvido Download PDFInfo
- Publication number
- BR112015029468A8 BR112015029468A8 BR112015029468A BR112015029468A BR112015029468A8 BR 112015029468 A8 BR112015029468 A8 BR 112015029468A8 BR 112015029468 A BR112015029468 A BR 112015029468A BR 112015029468 A BR112015029468 A BR 112015029468A BR 112015029468 A8 BR112015029468 A8 BR 112015029468A8
- Authority
- BR
- Brazil
- Prior art keywords
- iron
- orally administrable
- mitigating
- unabsorbed
- human subject
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/04—Chelating agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
sistema de dosagem não alimentar oralmente administrável; composição oralmente administrável; método para suplementar a nutrição de ferro em um indivíduo humano com necessidade do mesmo; método para mitigar um ou mais efeitos adversos gastrointestinais de ferro não absorvido. resumo a presente invenção se refere a um sistema de dosagem oralmente administrável compreende (a) ferro em uma forma de um ou mais tipos de ferro fisiologicamente aceitáveis compostos e/ou complexos; e (b) um agente para mitigar um ou mais efeitos adversos gastrointestinais de ferro não absorvido, o referido agente compreendendo um ou ambos de um componente de zinco e um componente quelante, o referido componente de zinco se presente compreendendo um ou mais compostos e/ou complexos de zinco fisiologicamente aceitáveis, e o referido componente quelante, se presente compreendendo um composto quelante de íons formulado para liberação distal para o local principal de absorção de ferro no duodeno. 1/1
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361831879P | 2013-06-06 | 2013-06-06 | |
PCT/US2014/039738 WO2014197250A1 (en) | 2013-06-06 | 2014-05-28 | Iron supplement |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112015029468A2 BR112015029468A2 (pt) | 2017-07-25 |
BR112015029468A8 true BR112015029468A8 (pt) | 2020-03-17 |
Family
ID=52005976
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015029468A BR112015029468A8 (pt) | 2013-06-06 | 2014-05-28 | sistemas de dosagem oralmente administráveis, método para suplementar a nutrição de ferro em um indivíduo humano e métodos para mitigar um ou mais efeitos adversos gastrointestinais de ferro não absorvido |
Country Status (12)
Country | Link |
---|---|
US (2) | US11331287B2 (pt) |
EP (1) | EP3003328B1 (pt) |
AU (1) | AU2014275307B2 (pt) |
BR (1) | BR112015029468A8 (pt) |
CA (1) | CA2913413C (pt) |
CR (1) | CR20150665A (pt) |
ES (1) | ES2895044T3 (pt) |
GT (1) | GT201500328A (pt) |
MX (1) | MX2015016660A (pt) |
PL (1) | PL3003328T3 (pt) |
WO (1) | WO2014197250A1 (pt) |
ZA (1) | ZA201508363B (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10653658B2 (en) | 2015-08-11 | 2020-05-19 | Akeso Biomedical, Inc. | Biofilm inhibiting compositions enhancing weight gain in livestock |
PL3334440T3 (pl) | 2015-08-11 | 2021-11-02 | Akeso Biomedical, Inc. | Kompozycje hamujące tworzenie biofilmu wspierające przyrost masy ciała u zwierząt gospodarskich |
US11083738B2 (en) * | 2017-09-28 | 2021-08-10 | Natals, Inc. | Dietary nutrient compositions |
MX2020004107A (es) | 2017-10-25 | 2020-07-24 | Chiesi Farm Spa | Tabletas de deferiprona de liberacion retrasada y metodos de uso de las mismas. |
US20230321060A1 (en) * | 2022-04-11 | 2023-10-12 | Chiesi Farmaceutici S.P.A. | Modified release pharmaceutical formulations comprising deferiprone |
US20230321061A1 (en) * | 2022-04-11 | 2023-10-12 | Chiesi Farmaceutici S.P.A. | Modified release pharmaceutical formulations comprising deferiprone |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL91047A (en) | 1989-07-19 | 1993-06-10 | Yissum Res Dev Co | Zinc complexes for the treatment of free radical- induced diseases |
US5536507A (en) * | 1994-06-24 | 1996-07-16 | Bristol-Myers Squibb Company | Colonic drug delivery system |
US5516925A (en) | 1994-08-23 | 1996-05-14 | Albion International, Inc. | Amino acid chelates having improved palatability |
US6521247B1 (en) * | 1999-08-13 | 2003-02-18 | Warner Chilcott Laboratories Ireland Limited | Dual iron containing nutritional supplement |
US7160855B2 (en) | 2002-03-14 | 2007-01-09 | Children's Hospital & Research Center At Oakland | Enhancement of iron chelation therapy |
US20060134227A1 (en) | 2004-12-22 | 2006-06-22 | Bortz Jonathan D | Compositions including iron |
CN1965697A (zh) | 2005-11-15 | 2007-05-23 | 王健柏 | 营养补血保健饮用制品 |
US8007846B2 (en) | 2006-01-18 | 2011-08-30 | Albion International, Inc. | Mixed amino acid/mineral compounds having improved solubility |
TW200843802A (en) * | 2007-02-09 | 2008-11-16 | Drugtech Corp | Compositions for improving gastrointestinal nutrient and drug absorption |
WO2009032699A1 (en) * | 2007-08-29 | 2009-03-12 | Drugtech Corporation | Anti-proliferative combinations |
WO2010136839A1 (en) | 2009-05-29 | 2010-12-02 | Carlo Ghisalberti | Use of deferoxamine and related compounds in targeted delivery forms to treat an inflammatory bowel disease |
CN101744120B (zh) | 2009-12-25 | 2012-04-11 | 河北农业大学 | 乳仔猪微量元素预混料 |
CN102318764B (zh) | 2011-08-30 | 2014-04-02 | 武汉天龙饲料有限公司 | 一种无抗仔猪教槽料及其制备方法 |
BR112014007022B1 (pt) | 2011-09-22 | 2021-02-09 | Amip | composição farmacêutica, método e uso de uma composição farmacêutica |
-
2014
- 2014-05-28 EP EP14807576.5A patent/EP3003328B1/en active Active
- 2014-05-28 PL PL14807576T patent/PL3003328T3/pl unknown
- 2014-05-28 MX MX2015016660A patent/MX2015016660A/es active IP Right Grant
- 2014-05-28 US US14/288,802 patent/US11331287B2/en active Active
- 2014-05-28 WO PCT/US2014/039738 patent/WO2014197250A1/en active Application Filing
- 2014-05-28 CA CA2913413A patent/CA2913413C/en active Active
- 2014-05-28 ES ES14807576T patent/ES2895044T3/es active Active
- 2014-05-28 AU AU2014275307A patent/AU2014275307B2/en active Active
- 2014-05-28 BR BR112015029468A patent/BR112015029468A8/pt not_active Application Discontinuation
-
2015
- 2015-11-12 ZA ZA2015/08363A patent/ZA201508363B/en unknown
- 2015-11-20 GT GT201500328A patent/GT201500328A/es unknown
- 2015-12-17 CR CR20150665A patent/CR20150665A/es unknown
-
2022
- 2022-04-12 US US17/718,538 patent/US20220233476A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2913413A1 (en) | 2014-12-11 |
AU2014275307B2 (en) | 2017-06-15 |
EP3003328B1 (en) | 2021-07-28 |
ZA201508363B (en) | 2017-09-27 |
WO2014197250A1 (en) | 2014-12-11 |
CA2913413C (en) | 2021-11-23 |
CR20150665A (es) | 2016-02-24 |
PL3003328T3 (pl) | 2022-01-24 |
MX2015016660A (es) | 2016-07-26 |
EP3003328A4 (en) | 2017-05-03 |
US20140364491A1 (en) | 2014-12-11 |
ES2895044T3 (es) | 2022-02-17 |
US20220233476A1 (en) | 2022-07-28 |
EP3003328A1 (en) | 2016-04-13 |
US11331287B2 (en) | 2022-05-17 |
AU2014275307A1 (en) | 2015-12-10 |
GT201500328A (es) | 2017-12-14 |
BR112015029468A2 (pt) | 2017-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112015029468A8 (pt) | sistemas de dosagem oralmente administráveis, método para suplementar a nutrição de ferro em um indivíduo humano e métodos para mitigar um ou mais efeitos adversos gastrointestinais de ferro não absorvido | |
MY188749A (en) | Compositions comprising a combination of nivolumab and ipilimumab | |
BR112015016997A2 (pt) | composto, composição farmacêutica e método para o tratamento ou prevenção de câncer de mama | |
BR112015022197A8 (pt) | uso de um composto para fabricação de um medicamento ou composição farmacêutica para o tratamento de cataplexia | |
BR112018012914A2 (pt) | composto, método para tratar, prevenir ou melhorar um ou mais sintomas de câncer, método para tratar, prevenir ou melhorar um ou mais sintomas de uma doença inflamatória e composição farmacêutica | |
UA118255C2 (uk) | Композиція, яка містить антитіло до cd38 і леналідомід | |
EA201691454A1 (ru) | Композиции придопидина модифицированного высвобождения | |
CY1117118T1 (el) | Φαρμακευτικος συνδυασμος για την αγωγη του πονου | |
MY184628A (en) | Afucosylated anti-fgfr2iiib antibodies | |
MX2018003569A (es) | Derivados de acido oleanolico modificado en c4 para la inhibicion de il-17 y otros usos. | |
MX368903B (es) | Compuestos terapéuticos y sus usos en el tratamiento de enfermedades proliferativas. | |
NZ702087A (en) | Pharmaceutical compositions and treatment of mastitis | |
MY176246A (en) | Compositions for oral administration of zoledronic acid or related compounds for treating disease | |
PH12015501783B1 (en) | Pharmaceutical compositions for the treatment of helicobacter pylori | |
EA201692481A1 (ru) | Комбинация, содержащая глюкокортикоид и edo-s101 | |
BR112015022846A2 (pt) | uso de um composto para tratar ou prevenir um angioedema mediado pelo receptor b2 da bradicinina e formulação compreendendo o mesmo | |
EA201991531A1 (ru) | Способы лечения композициями линаклотида с отсроченным высвобождением | |
MX2015015667A (es) | Composicion que comprende un complejo de (+)-catequina y aminoacido para el tratamiento y prevencion de cancer. | |
CL2020003153A1 (es) | Composiciones antimicrobianas con agentes efervescentes (divisional de solicitud n° 03273-2016) | |
EA201291384A1 (ru) | Терапевтические агенты 976 | |
BR112018077440A2 (pt) | uma composição para uso no tratamento de infecção de rotavírus | |
PH12015502560B1 (en) | Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease | |
PH12016502547A1 (en) | Methods for treating infections | |
MX2016003763A (es) | Terapia de combinacion con laquinimod para tratamiento de esclerosis multiple. | |
MA38426B1 (fr) | Compositions antibiotiques de ceftolozane |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] |